These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 8221956)

  • 1. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
    Ni SS; Gao ZL
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions.
    Chang SC; Hsu YT; Chen YC; Lin CY
    Arch Intern Med; 1994 May; 154(10):1097-101. PubMed ID: 8185423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural fluid and serum soluble interleukin-2 receptors in pleural effusions.
    Sarandakou A; Poulakis N; Rizos D; Phocas I
    Anticancer Res; 1991; 11(3):1365-8. PubMed ID: 1888173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid.
    Porcel JM; Gázquez I; Vives M; Pérez B; Rubio M; Rivas MC
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):975-9. PubMed ID: 11055766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
    Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
    Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of soluble interleukin-2 receptors in tuberculous pleural effusions.
    Ito M; Kojiro N; Shirasaka T; Moriwaki Y; Tachibana I; Kokubu T
    Chest; 1990 May; 97(5):1141-3. PubMed ID: 2331910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic significance of gamma-interferon in tuberculous pleurisy.
    Poyraz B; Kaya A; Ciledağ A; Oktem A; Gönüllü U
    Tuberk Toraks; 2004; 52(3):211-7. PubMed ID: 15351932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated soluble CD26 levels in patients with tuberculous pleurisy.
    Oshikawa K; Sugiyama Y
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):868-72. PubMed ID: 11573900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating tuberculous from malignant pleural effusions: a scoring model.
    Porcel JM; Vives M
    Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
    Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
    J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleural effusion and serum soluble fas-ligand levels are elevated in different clinical conditions.
    Wang PS; Chen YM; Hsieh YL; Yu CF; Tsai CM; Perng RP
    Lung; 2002; 180(1):25-32. PubMed ID: 12105754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of vascular endothelial growth factor (VEGF) in neoplastic and tuberculosis effusions--preliminary results].
    Jankowska R; Porebska I; Dyła T
    Pneumonol Alergol Pol; 2002; 70(5-6):258-64. PubMed ID: 12518624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
    Kojiro N; Moriwaki Y; Ito M; Nishiki M; Shirasaka T; Kokubu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):100-4. PubMed ID: 2355670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble interleukin-6 receptor levels in pleural effusions.
    Yokoyama A; Kohno N; Fujino S; Abe M; Ishida O; Hiwada K
    Respir Med; 1996 Jul; 90(6):329-32. PubMed ID: 8759474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
    Zhou J; Zhao Q; Yao H
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of detecting E-selectin of serum and pleural effusion in differentiating benign and malignant diseases].
    Liu G; Li C; Zhong X
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):556-8. PubMed ID: 11360510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
    Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
    Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion.
    Kim YK; Lee SY; Kwon SS; Kim KH; Moon HS; Song JS; Park SH
    Lung; 2001; 179(3):175-84. PubMed ID: 11891607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evaluation of soluble IL-2 receptor and type III procollagen N-terminal aminopeptide in pleural fluid for differentiating tuberculous, carcinomatous and parapneumonic pleural effusions.
    Harita S; Nogami N; Kikuchi T; Kibata M
    Respirology; 2002 Dec; 7(4):311-5. PubMed ID: 12421238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.